Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

14.28
Delayed Data
As of Aug 28
 0.00 / 0.00%
Today’s Change
5.34
Today|||52-Week Range
19.43
+134.10%
Year-to-Date

Today’s Trading

Previous close14.28
Today’s open14.24
Day’s range14.02 - 14.88
Volume1,342,012
Average volume (3 months)1,943,069
Market cap$1.2B
Dividend yield--
Data as of 08/28/2015

Growth & Valuation

Earnings growth (last year)+14.46%
Earnings growth (this year)-100.66%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+42.82%
P/E ratioNM
Price/Sales14.46
Price/Book35.22

Competitors

 Today’s
change
Today’s
% change
ESPREsperion Therapeutic...+0.50+0.96%
AXONAxovant Sciences Ltd-0.60-4.81%
ATRAAtara Biotherapeutic...+0.25+0.63%
CHRSCoherus BioSciences ...+0.44+1.54%
Data as of 08/28/2015

Financials

Next reporting dateOctober 23, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$85.5M
Annual profit (last year)-$60.7M
Net profit margin-71.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers